Patient education programme | |
First meeting (before admission) | |
◦ Level of motivation, ambivalence, pros and cons | |
Second meeting (after 1 week) | |
◦ Dependence, withdrawal symptoms (experience and expectations) | |
Third meeting (after 2 weeks) | |
◦ Relapse (description and management) | |
Fourth meeting (after 3 weeks) | |
◦ Benefits of short and long term smoking and/or alcohol abstinence | |
Fifth meeting (after 5 weeks) | |
◦ Continued smoking abstinence and/or reduced alcohol intake following intervention | |
At each meeting | |
Smokers: Personalized Nicotine Replacement Therapy (NRT) in accordance with patient preferences and nicotine dependency | |
Risky drinkers: Thiamine and B-vitamins (300 mg × 7 weekly) | |
Alcohol withdrawal prophylaxis and treatment (chlordiazepoxide 10 mg as required) | |
Disulfiram (200 mg × 2 weekly) supervised at weekly meetings (not administrated if patients test positive on breath test) | |
All: Hemoglobin, liver enzymes and alcohol biomarkers (blood, urine), CO and alcohol breath test, lung function test | |
The study medication is provided for free and transportation for the weekly meetings will be reimbursed. Patients have telephone access to the research nurse |